...
首页> 外文期刊>Jornal de Pediatria >Acute Myeloid Leukemia: analysis of epidemiological profile and survival rate a??
【24h】

Acute Myeloid Leukemia: analysis of epidemiological profile and survival rate a??

机译:急性骨髓性白血病:流行病学特征和生存率分析

获取原文

摘要

Objective: To describe the epidemiological profile and the survival rate of patients with acute myeloid leukemia (AML) in a state reference pediatric hospital. Method: Clinical-epidemiological, observational, retrospective, descriptive study. The study included new cases of patients with AML, diagnosed between 2004 and 2012, younger than 15 years. Results: Of the 51 patients studied, 84% were white; 45% were females and 55%, males. Regarding age, 8% were younger than 1 year, 47% were aged between 1 and 10 years, and 45% were older than 10 years. The main signs/symptoms were fever (41.1%), asthenia/lack of appetite (35.2%), and hemorrhagic manifestations (27.4%). The most affected extra-medullary site was the central nervous system (14%). In 47% of patients, the white blood cell (WBC) count was below 10,000/mm 3 at diagnosis. The minimal residual disease (MRD) was less than 0.1%, on the 15th day of treatment in 16% of the sample. Medullary relapse occurred in 14% of cases. When comparing the bone marrow MRD with the vital status, it was observed that 71.42% of the patients with type M3 AML were alive, as were 54.05% of those with non-M3 AML. The death rate was 43% and the main proximate cause was septic shock (63.6%). Conclusions: In this study, the majority of patients were male, white, and older than 1 year. Most patients with WBC count <10,000/mm 3 at diagnosis lived. Overall survival was higher in patients with MRD <0.1%. The prognosis was better in patients with AML-M3.
机译:目的:描述一家国家参考儿科医院的急性髓细胞性白血病(AML)患者的流行病学概况和生存率。方法:临床流行病学,观察,回顾性,描述性研究。该研究包括2004年至2012年之间诊断的15岁以下的新的AML患者病例。结果:在研究的51例患者中,84%为白人。女性占45%,男性占55%。关于年龄,年龄在1岁以下的占8%,年龄在1至10岁之间的占47%,年龄在10岁以上的占45%。主要体征/症状为发烧(41.1%),乏力/食欲不振(35.2%)和出血表现(27.4%)。受影响最大的髓外部位是中枢神经系统(14%)。在诊断时,有47%的患者白细胞(WBC)计数低于10,000 / mm 3。在治疗的第15天,有16%的样本中的最小残留疾病(MRD)小于0.1%。髓样复发发生在14%的病例中。将骨髓MRD与生命状态进行比较时,观察到71.42%的M3 AML患者还活着,非M3 AML患者中54.05%仍然活着。死亡率为43%,最直接的原因是败血性休克(63.6%)。结论:在这项研究中,大多数患者是男性,白人和1岁以上。诊断时大多数白细胞计数<10,000 / mm 3的患者都活着。 MRD <0.1%的患者的总生存率更高。 AML-M3患者的预后较好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号